i There was lack of Government support for levying anti-dumping duty
 despite efforts of the Company. Hence, the Company has suspended the
 production of Penicillin-'' as import from China have resulted in
 unviable prices. 
 
 The Company is in process of exploring other alternative options to
 utilize its manufacturing capacity.
 
 ii The remuneration paid to Managerial / Whole Time Director is in
 excess of the remuneration prescribed under schedule XIII to the
 Companies Act, I956 .The Company is in process of making an application
 for the necessary approval from the Central Government for the excess
 paid remuneration in the prescribed limits.
 
 iii. As per information / documents available with the Company, there
 are no small scale undertaking. Hence information as per requirement
 of section 22 of Micro, Small & Medium Enterprises Development Act,
 2006, not given.
 
 iv.  Segment Reporting
 
 Primary Segment
 
 The Company has identified Pharmaceuticals and Real Estate as
 the primary reportable segment.
 
 The Company has started a real estate project for residential use. The
 project is in initial stage and no revenue / profit is recognized in the
 current quarter / period and therefore, the Company has reported only
 pharmaceutical segment in accordance with the Accounting Standard on
 Segment Reporting (AS-I7).
 
 In view of the inter-woven/inter-mixed nature of business and
 manufacturing facility, other secondary segmental information is not
 ascertainable.
 
 v Listing Agreement clause 32 disclosure
 
 Disclosures as required under clause 32 of listing agreement have not
 been given as there are no such transactions with any such party /
 Employee.
 
 vi During the year ended 3Ist March, 20I2 the revised schedule VI
 notified under the Companies Act, I956 has become applicable to the
 Company for perpetration and presentation of its financial statement.
 The adoption of revised schedule VI does not impact recombination and
 measurement principles followed for preparation of financial
 statements.  However, it has significant impact on presentation and
 disclosures made in the financial statements. The company has also
 reclassified the previous year''s figures in accordance with the
 requirements applicable in the current year. In view of this
 reclassification certain figures of current year are not strictly
 comparable with those of the previous year.